These findings strengthen the conclusion that PAX5 germline variants can cause B-ALL susceptibility and are associated with specific additional genetic lesions to initiate overt B-ALL [32]. This evidence concerns the gene PAX5 and precursor B-cell acute lymphoblastic leukemia.